Oxford Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,135
| Closed | -$11.6K | – | 662 |
|
|
2025
Q1 | $11.6K | Buy |
+1,135
| New | +$11.6K | 0.01% | 452 |
|
|
2020
Q1 | – | Sell |
-5,083
| Closed | -$1.65M | – | 911 |
|
|
2019
Q4 | $1.65M | Buy |
+5,083
| New | +$1.65M | 0.05% | 543 |
|
|
2019
Q1 | – | Sell |
-3,872
| Closed | -$1.91M | – | 1871 |
|
|
2018
Q4 | $1.91M | Buy |
3,872
+2,178
| +129% | +$1.07M | 0.05% | 491 |
|
|
2018
Q3 | $1.55M | Buy |
+1,694
| New | +$1.55M | 0.03% | 805 |
|
|
2017
Q2 | – | Sell |
-9,578
| Closed | -$3.37M | – | 1623 |
|
|
2017
Q1 | $3.37M | Sell |
9,578
-2,882
| -23% | -$1.01M | 0.08% | 241 |
|
|
2016
Q4 | $2.29M | Sell |
12,460
-21,527
| -63% | -$3.96M | 0.08% | 286 |
|
|
2016
Q3 | $8.76M | Buy |
33,987
+11,201
| +49% | +$2.89M | 0.27% | 86 |
|
|
2016
Q2 | $4.86M | Buy |
22,786
+4,873
| +27% | +$1.04M | 0.16% | 151 |
|
|
2016
Q1 | $3.69M | Buy |
17,913
+2,693
| +18% | +$555K | 0.11% | 243 |
|
|
2015
Q4 | $3.87M | Buy |
15,220
+11,928
| +362% | +$3.03M | 0.09% | 240 |
|
|
2015
Q3 | $541K | Buy |
+3,292
| New | +$541K | 0.02% | 485 |
|
|
2014
Q1 | – | Sell |
-3,632
| Closed | -$618K | – | 726 |
|
|
2013
Q4 | $618K | Sell |
3,632
-1,030
| -22% | -$175K | 0.02% | 568 |
|
|
2013
Q3 | $731K | Sell |
4,662
-5,127
| -52% | -$804K | 0.02% | 613 |
|
|
2013
Q2 | $1.7M | Buy |
+9,789
| New | +$1.7M | 0.05% | 485 |
|